Please select the option that best describes you:
What sites for SBRT are thought to be more immunogenic for antigen presentation when combined with immunotherapy?
If given options of liver, lung, spine, brain, axilla, or other lymph nodes which sites do you pick?
Answer from: Radiation Oncologist at Academic Institution
I am aware of only one prospective trial structured to approach this question to some extent. It was from Jim Welsh's team at MDAH and was presented at ASTRO this year.http://www.redjournal.org/article/S0360-3016(17)33877-4/abstractThere was a hint that sequential ipilimumab followed by RT to lung l...
Sign in or Register to read more